What the hell is going on with EVFL, my man?

Damn!

Stocks to watch this week, my man

BioElectronics Corporation (Public, OTC:BIEL) 0.0720

BIOCENTRIC ENGY HLDGS INC (Public, PINK:BEHL) 0.0540

Ecotality, Inc. (Public, OTC:ETLY) 0.125

EVEROCK INC (Public, PINK:EVRN) 0.0260

Evolution Fuels, Inc. (Public, OTC:EVFL) 0.0002

Global General Technologies Inc (Public, OTC:GLGT) 0.0120

GOOD LIFE CHINA CORP (Public, PINK:GLCC) 0.0015

Hard To Treat Diseases (Pink: HTDS) 0.0111

IDEAL FINANCIAL SLTNS INC (Public, PINK:IFSL) 0.0053

Inrob Tech, Ltd. (Public, OTC:IRBL) 0.0013

Lehman Brothers Holdings Inc. (Public, OTC:LEHMQ) 0.153

NMT Medical, Inc. (Public, NASDAQ:NMTI) $1.95

Solomon Technologies, Inc. (Public, OTC:SOLM) 0.0150

Have a good weekend, my little mans

Speculative pick of the day: Guangzhou Global Telecom (GZGT), my man

From their web site: Guangzhou Global Telecom, Inc. is a U.S. company that is publicly traded on the NASDAQ OTC_BB under the ticker symbol GZGT.

Guangzhou Global Telecom, Inc. operates in China through Guangzhou Global Telecom Co., Ltd. (GGT), a wholly owned subsidiary of Global Telecom Holding Limited, which is a wholly owned subsidiary of Guangzhou Global Telecom, Inc.

Currently trading at 0.0109

Words of wisdom, my man

Don't forget about Hana Biosciences, (NASDAQ:HNAB), my man

This is worth a look, my man. Hana Biosciences is currently trading at 0.57, my man.

I got 800 shares of RegeneRx Biopharmaceuticals, Inc. (AMEX:RGN), my man

I've been looking at RegeneRx Biopharmaceuticals and MYMAN decided it was time to dive in, my man. I got 800 shares at .64 cents for $512. I generally try to keep investments per stock under $500 a pop. Just a rule I try to follow to keep myself from spending too much but MYMAN thinks RGN has got potential.

HTDS, my man

Hard to Treat Diseases Inc. (HTDS)

Aug 24 7:54 PM EDT

Last Price 0.011 Change 0.0025 Day High 0.012 Bid N/A Ask N/A Dividend 0.00

Last Trade 3:59 % Change 29.41% Day Low 0.0085 Bid Size N/A AskSize N/A Ex-Div Date N/A

Tick Open 0.0087 52 Wk Hi 0.0219 EPS(TTM) N/A Shares 22.09 m Yield 0.00

Volume 196.38 m Prev Close 0.0085 52 Wk Low 0.0001 PE Ratio N/A Market Cap close Exchange Information Listed On Other-OTC (OTO) 243.02 k Exchange OTO

Crazy day for HTDS, my man

Just go to China Bio Today and see what they say about HTDS, my man

Just go to their site search for "Hard to Treat Diseases", my man. This is a playa', my man.

About HTDS: 'China Biotech in Review: The Business of China Life Science', my man

From Seeking Alpha:

China Biotech in Review: The Business of China Life Science

August 16, 2009

Most of the stories emanating from the world of China life science had to do with the business side of the segment: an IPO, a possible takeover, new capital and earnings – lots of earnings. In addition, there were cross-border deals that will introduce new products to China and China products to the rest of the world, plus new product approvals and China-France collaborative research...

...Shenzhen Mellow Hope Pharm Industrial Co., a subsidiary of Hard to Treat Diseases [Pink Sheets: HTDS], has reached an agreement to be the sole international distributor of a Recombinant Hepatitis B vaccine manufactured by North China Pharmaceutical Group (see story). NCPC is a large state-owned pharmaceutical company, with a specialty in vaccines.

get rich or die tryin'

MYMAN rates MultiCell Technologies, Inc. (OTC:MCET) a BUY, my man

Buy this bitch now, my man MCET 0.0300 +0.0215 (252.94%) She's in heat.

The art of stock picking, my man

Stocks to consider for the long-term, my man

MYMAN understands you have to be patient when it comes to investing, my man. Below are some stocks that MYMAN is looking at and thinks might turn out to be money-makers down the road. If you are willing to wait six months or more, consider these companies, my man:

Vycor Medical Inc. (OTC:VYCO) - Currently trading at 0.03000

Vycor Medical, Inc. is a developer of neurosurgical medical devices.

Medical International Technology Inc (OTC:MDLH) - Currently trading at 0.0900

Medical International Technology specializes in the research, development, marketing and sale of needle-free jet injector products designed for humans and animals, for single and mass injections. Medical International Technology, Inc. markets several Models of Agro-Jet Needle-Free injectors. The AGRO-JET Model MIT II, MIT III, MIT V, MIT VI, MIT X, MIT XI, MIT XII and MIT XIV. The Company has tree wholly owned subsidiaries, Medical International Technologies Canada, Inc. (MIT Canada), 3567940 Canada inc. and ScanView. ScanView has a portable and battery operated ultrasound diagnostic medical devices, using a variety of probes for pathological and physiological evaluation of organs, such as the heart, kidneys, liver, thyroid, uterus and ovaries.

NeoPharm, Inc. (OTC:NEOL) - Currently trading at 0.230

NeoPharm has five drug product candidates in various stages of clinical and pre-clinical development for the treatment of cancer and one drug product candidate in pre-clinical development for treatment of interstitial pulmonary fibrosis (IPF) and asthma.

Inhibitex, Inc. (NASDAQ:INHX) - Currently trading at 0.440

Inhibitex is a biopharmaceutical company focused on the development of differentiated anti-infective products to prevent and treat serious infections. The Company focuses in the development of small molecule antiviral compounds, and in particular, therapies to treat shingles (herpes zoster) and chronic hepatitis C infections (HCV). The Company’s anti-infective product candidates include FV-100, HCV Polymerase Inhibitors, HIV Integrase Inhibitors, Aurexis and Staphylococcal Vaccines.

RegeneRx Biopharmaceuticals, Inc. (AMEX:RGN) - Currently trading at 0.590

As of December 31, 2008, RegeneRx had formulated three product candidates based on Thymosin beta 4 (Tb4), a 43-amino acid peptide, which are in clinical development. RGN-137 is a topically applied gel for hard-to-heal chronic dermal wounds. RGN-259 is a sterile, preservative-free topical eye drop for ophthalmic wounds. RGN-352 is a parenteral or injectable formulation for systemic delivery of Tb4 to treat cardiovascular disease. The Company is initially targeting its parenteral formulation for the treatment of patients with an acute myocardial infarction or heart attack. RegeneRx has a fourth product candidate, RGN-457, in pre-clinical development. RGN-457 is an inhaled formulation of Tb4 targeting cystic fibrosis and other pulmonary diseases.

HTDS isn't the only hot Asian stock out there, my man

MYMAN also likes China Sun Group, (CSGH), my man

China Sun Group High Tech Co. (OTC:CSGH) currently at $1.11, my man.

MYMAN issues buy rating for China BAK Battery Inc.(NASDAQ:CBAK), my man

MYMAN loves Chinese food, Chinese women and he loves makin' money with Chinese companies. He's issuing a buy rating for China BAK Battery Inc. (NASDAQ:CBAK) which is his way of sayin' buy CBAK, my man.

China's automotive industry is just starting to grow and its already big, my man. And don't doubt for a second that you won't be seeing electric Chinese cars someday because they are developing and makin' them at this moment, my man. Chinese cars will someday be the U.S. and they will be sellin' them cheaper than that Chevy Volt, my man. CBAK is currently at $2.95

And they make battery cells for all kinds of things, my man. Not just cars:

China BAK Battery, Inc. is engaged in manufacturing rechargeable lithium-based battery cells. It produces battery cells that are the principal component of rechargeable batteries used to power applications, such as cellular phones, notebook computers, portable consumer electronics, such as digital cameras, portable media players, portable gaming devices and personal digital assistants (PDA), and other applications, such as cordless power tools, mining lamps, light electric vehicles and hybrid electric vehicles. Its products are packed into batteries by third-party battery pack manufacturers in accordance with the specifications of manufacturers of portable electronic applications. Its prismatic cells are targeted at the People’s Republic of China replacement market, where cellular phone batteries produced by independent battery manufacturers are purchased for use in second-hand cellular phones or as back-up batteries, and primarily comprises steel-case cells.

Yes, my man

MYMAN still rates HTDS a buy but here are some others to consider, my man

AMNE, HRNF, EPGL, LDSR, TYRIA, LFBG, MONA, ZVTK, BONU, CEGE, HEB, CTIC, AVVH, CCTR, EVFL

Consider Pluristem Therapeutics Inc. (NASDAQ:PSTI), my man

Pluristem Therapeutics Inc. (NASDAQ:PSTI) is moving up, my man. Currently at $1.62 and she was $28 just a couple of years ago, my man.

Don't worry about HTDS, my man

MYMAN is sticking with HTDS, my man. MYMAN expects HTDS to be least 0.05 to 0.10 by October.

What's hot at the moment, my man

(All stock quotes listed below are as of after close of market, Monday, August 17th):

OPTIGENEX INC (OPGX.PK) 0.0009 +0.0001 (12.50%)

Human BioSystems (OTC:HBSY) +0.029 (16.69%)

NutriPure Beverages NBVG.PK 0.0012 +0.0003 (33.33%)

Penn Treaty American Corp. (PTYA.PK) 0.384 +0.104 (37.14%)

SymPowerco Corporation (Pinksheets: SYMW) +0.0007 (63.64%)

ivoice Inc. (IVOI) 0.0002 +0.0001 (100.00%)

Mm2 Group Inc. (MMGP) 0.0005 +0.0003 (150.00%)

GOOD LIFE CHINA CORP (GLCC.PK) 0.0011 +0.0008 (266.67%)

If you choose right you'll get what you want, my man

If you choose right you'll get what you want, my man

MYMAN rates Ariad Pharmaceuticals a BUY (ARIA)

ARIA is currently at $1.95 and is waiting for results from a Phase 3 trial, my man.

MYMAN talks about HTDS, my man

AVVAA World Health Care Products Inc. (AVVH), my man

Very steady climb up this week for AVVH, my man:

MYMAN's odd pick of the day: Cycle Country Accessories Corp. (ATC)

Based in Spencer, IA. Cycle Country Accessories Corp., together with its subsidiaries, engages in the design, manufacture, sale, and distribution of accessories for all terrain vehicles (ATVs) and utility terrain vehicles (UTVs). Currently trading at 0.4076. Normally ATC trades in the $2 to $3 range, fairly steadily, my man. Was once as high as $6.30 at the end of 2004, my man. Hurt by the current economic situation but seems to be makin' a comeback my man. Not an explosive stock but might be something nice and stable to park your money in, my man.

MYMAN is looking at VIASPACE (OTC: VSPC), my man

VIASPACE is a clean energy company providing products and technology for renewable and alternative energy that reduce or eliminate dependence on fossil fuels and other high-pollutant energy sources. Through its subsidiaries, the Company provides raw material for cellulosic biofuels; develops and markets fuel cartridges, products and technology for methanol fuel cells; markets rechargeable lithium-ion batteries; and is developing security-related monitoring and detection technology and systems for military/defense and commercial applications.

Based in Irvine, CA and is currently trading at 0.02. Volume:1,351,274

MYMAN has no firm opinion on VSPC as of yet, my man but it looks interesting and he'll come out with a judgment later, my man.

Hang on to HTDS and you will be rewarded, my man

Panicky chump-ass fools are sellin' HTDS, my man

More shares for MYMAN!

MYMAN issues positive outlook on Genta Incorporated (GETA)

Yes, my man: 0.415 +0.030 (7.79%) Try to get in this one too, my man.

HTDS dipping a little but don't worry, my little mans

HTDS will take care of us all, my man. Currently at 0.0173 -0.0002 (-1.14%) Q2 report coming out real soon, MYMAN thinks sees HTDS at 0.05 by the end of the month, for sure, my man.

Avvaa World Health Care Products (AVVH) continues to climb, my man

Currently trading at 0.0080 +0.0013 (19.40%) .....maybe this is the next HTDS?

Consider China Crescent Enterprises (CCTR), my man

CCTR got’s potential, my man. Here are the current numbers as MYMAN writes this: 0.0670 +0.0110 (19.64%). MYMAN just got 1,000 shares of CCTR.

James Fry was right about InternetArray Inc (OTC:INAR), my man

Good call, my man! 0.0048 +0.0027 (128.57%)

Hard To Treat Diseases (HTDS) continues to soar, my man

0.0175 +0.0042 (31.58%) ............almost 2 cents today, my man. Don't worry, it WILL get there, soon, my man. Load up, if you can, my man.

Avvaa (AVVH) moves up today, my man

Final numbers today: 0.0067 +0.0024 (55.81%), not bad, my man.

Avvaa World Health Care Products Inc. (OTC: AVVH)

MYMAN is looking at Avvaa World Health Care Products Inc. (OTC: AVVH)

Currently trading at: 0.0043

From their web site: avVaa World Health Care Products, Inc. is a biotechnology company dedicated to providing effective therapeutic skin care products that improve the quality of life and well-being for global customers. Based in Lumby, British Columbia....NO MYMAN comment yet.

If you got HTDS money, get the honey, my man

So what is the next HTDS, my man?

This seems the biggest question right now, my man. Right after, "How high will HTDS go, my man?". MYMAN thinks HTDS is going to continue to do very well, my man. MYMAN expects HTDS to reach .05 by next month, for sure. It could happen by end of August, my man. See what happens with HTDS earnings, my man. But even if they was bad, I still think HTDS is a stock to own. Their earnings would have to be REALLY BAD for him to say otherwise, my man.

So what's next? BIEL is still quality and she'll be .15 to .20 cents soon enough.

There are many cheap stocks out there with potential and I list some of them here, my man. But MYMAN wants your feedback because not even he knows everything that's out there and tell us all what you think is the next HTDS:


Atlantis Technology Group (ATNO.PK)

AmeriResource Technologies, Inc. (OTC:ARIO)

The BlackHawk Fund (OTC:BHWF)

CardioVascular BioTherapeutics, Inc. (OTC:CVBT)

China Biopharma Inc. (OTC:CHBO)

China Health Resource, Inc. (Public, OTC:CHRI)

COPPER KING MINING CORP (PINK:CPRK)

EP Global Communications, Inc. (Public, OTC:EPGL)

Evolution Fuels, Inc. (Public, OTC:EVFL)

Globalstar, Inc. (NASDAQ:GSAT)

Human BioSystems (OTC:HBSY)

IQ Micro Inc. (OTC:IQMC)

LTWC Corporation (OTC:LTWC)

SYMPOWERCO CORP (Public, PINK:SYMW)

Trey Resources Inc. (OTC:TYRIA)

VIPR INDUSTRIES INC (PINK:VIPR)

Wellstar International, Inc. (OTC:WLSI)

ZENERGY INTL INC (Public, PINK:ZENG)

HTDS, my man!

HTDS had an awesome day, my man.

BIEL slipped a little but it held it's own. Both are still BUY and HOLDS with potential especially HTDS sinceit is still cheap, my man. MYMAN sees a nickle in HTDS's next big stop on the chart, my man.

Zahra Burton, my man

HTDS does her thing again today, my man

Going up, up, up, my man. 0.0063!

This week may be all about BIEL and HTDS, my man

Yes, my man.

MYMAN rates CardioVascular BioTherapeutics a BUY, my man

CardioVascular BioTherapeutics, Inc. (CVBT.PK) my man. Check her out:

CardioVascular BioTherapeutics, Inc., a development stage biopharmaceutical company, focuses on developing and marketing protein drug candidates used in the treatment of cardiovascular disease. The company uses an active pharmaceutical ingredient, the 141 acidic human form of fibroblast growth factor-1, in its drug candidates, which facilitates the growth of new blood vessels in the heart tissues and organs with an impaired vascular system. Its products under development include CVBT-141A, a Phase I clinical trial completed product for use in the treatment of severe coronary heart disease; and CVBT-141B, a Phase I clinical trial completed product for the treatment of wound healing; CVBT-141C, a Phase I clinical trial product for the treatment of peripheral artery disease; and CVBT-141H, a Phase I clinical trial product for the treatment of severe coronary heart disease. The company’s pre-clinical research and development stage products comprise CVBT-141E for the treatment of lumbar ischemia, and CVBT-141F for bone repair. In addition, CardioVascular BioTherapeutics’ product portfolio includes CVBT-141D, which is under proof of concept clinical trials stage for the treatment of disc ischemia. The company was founded in 1998. It was formerly known as CardioVascular Genetic Engineering, Inc. and changed its name to CardioVascular BioTherapeutics, Inc. in 2004. The company is headquartered in Las Vegas, Nevada.